Biotinyl-Tau Peptide (306-336) (Repeat 3 Domain) (human) |
| カタログ番号GA20848 |
タウの4回繰り返しマイクロチューブ結合ドメインの第3フラグメント（306-336）の両親媒性螺旋構造が、神経病理学的フィラメント形成の原因であると仮説されています。さらに、バイオチン基はアビジンまたはストレプトアビジンと高い特異性および親和力で結合し、堅牢な結果を提供します。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2022956-58-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
The amphipathic helical structure of the third fragment (306-336), in the four-repeat microtubule-binding domain of tau, is hypothesized to be responsible for the formation of the neuropathological filament. The additional biotin moiety will bind avidi
Average Rating: 5 (Based on Reviews and 8 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *